BDP® 650/665 maleimide
Cat. # | Quantity | Price | Lead time | Buy this product |
---|---|---|---|---|
18480 | 1 mg | $125 | in stock | |
28480 | 5 mg | $260 | in stock | |
48480 | 25 mg | $510 | in stock | |
58480 | 50 mg | $895 | in stock | |
68480 | 100 mg | $1490 | in stock |
BDP 650/665 is a bright, red-emitting fluorophore for Cyanine5 (Cy5) channel. The dye has a high molar extinction coefficient and a good emission quantum yield. The dye is moderately hydrophobic but can be used to label biomolecules in an aqueous environment, so it is a good alternative to Cy5.
Maleimide is a thiol-reactive group. The compound can be used for the labeling of cysteine residues of proteins and peptides, among other SH-containing molecules.
Absorption and emission spectra of BDP 650/665
Recommended protocol
Calculator
Customers also purchased with this product
BDP® TMR maleimide
A bright, thiol reactive dye for TAMRA channel. Useful for microscopy and fluorescence polarization assays, among other applications.3-Ethynylperylene
Alkyne derivative of ultra-bright and photostable perylene fluorophore.Annexin V-AF 488 conjugate
Annexin V-AF 488 conjugate for detection of apoptotic cells by flow cytometry and fluorescence microscopy.General properties
Appearance: | dark colored solid |
Mass spec M+ increment: | 555.2 |
Molecular weight: | 555.34 |
Molecular formula: | C29H24N5BF2O4 |
Solubility: | good in DMF, DMSO, low in water |
Quality control: | NMR 1H, HPLC-MS (95%) |
Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
MSDS: | Download |
Product specifications |
Spectral properties
Excitation/absorption maximum, nm: | 649 |
ε, L⋅mol−1⋅cm−1: | 94000 |
Emission maximum, nm: | 667 |
Fluorescence quantum yield: | 0.52 |
CF260: | 0.04 |
CF280: | 0.04 |
Product citations
- Massó-Vallés, D.; Beaulieu, M.-E.; Jauset, T.; Giuntini, F.; Zacarías-Fluck, M. F.; Foradada, L.; Martínez-Martín, S.; Serrano, E.; Martín-Fernández, G.; Casacuberta-Serra, S.; Castillo Cano, V.; Kaur, J.; López-Estévez, S.; Morcillo, M. Á.; Alzrigat, M.; Mahmoud, L.; Luque-García, A.; Escorihuela, M.; Guzman, M.; Arribas, J.; Serra, V.; Larsson, L.-G.; Whitfield, J. R.; Soucek, L. MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding. Cancer Research Communications, 2022, 2(2), 110–130. doi: 10.1158/2767-9764.CRC-21-0103
BDP® is a trademark of Lumiprobe
This Product is offered and sold for research purposes only. It has not been tested for safety and efficacy in food, drug, medical device, cosmetic, commercial or any other use. Supply does not express or imply authorization to use for any other purpose, including, without limitation, in vitro diagnostic purposes, in the manufacture of food or pharmaceutical products, in medical devices or in cosmetic products.
Your item has been added.
View your
cart
or
proceed to checkout
The count of items is incorrect.